Machine Party truly is masochistic Mario Party. You need at least two people to play, and it can run up to four people, with ...

GLP-1 drugs could lead to cost savings for workers and their employers by reducing employee sick leave, a new economic study finds. Researchers found that patients who used the drugs, sold under brand ...

Novo Nordisk (NYSE:NVO) stock is down 1% at $49.14, after the drugmaker filed a lawsuit against rival Eli Lilly (LLY), citing misleading advertising for its GLP-1 drugs. The company said it wants ...

Wolfy plays a level made just for him in Super Mario Maker 2.

Novo Nordisk sued rival drugmaker Eli Lilly, alleging false advertising claims about relative weight-loss drug performance. (Reuters via NBC News) GLP-1 drug use surged from 2017 to 2022, jumping 230% ...

America is slimming down — one shot at a time. The number of US adults turning to blockbuster GLP-1 drugs like Ozempic and Wegovy for weight loss has hit a record high, nearly quadrupling in just two ...

(NEXSTAR) – Insurance coverage just changed for as many as 56 million Americans when it comes to the popular GLP-1 medications used to promote weight loss. Medicare announced it is offering certain ...

Some Medicare patients will be able to access to GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more ...

To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo Novo Nordisk, the maker of Wegovy, introduced its GLP-1 pill for weight loss in early January ...

Studying the epic journey of the iconic jumping plumber can lead to new insights in theoretical computer science—and may help researchers understand the tractability of problems in other areas. Here’s ...

(NEXSTAR) – A new study from the University of Georgia put popular GLP-1 medications head-to-head, testing which one is the most effective for weight loss. The study compared three types of the ...

The boom in GLP-1 weight-loss drugs is boosting demand for protein supplements and driving a rally in the stock of Glanbia Plc, a maker of nutrition products popular with gym enthusiasts and athletes.